Management of endometriosis through a combined medical-surgical approach;WAS LEISTET DIE KOMBINIERTE CHIRURGISCH-HORMONELLE TYHERAPIE ZUM MANAGEMENT DER ENDOMETRIOSE?

Zentralblatt fur Gynakologie

Volumn 120, Issue 4, 1998, Pages 183-190

  Schindler, A E ^a   Buhler K ^a   Lubben G ^b   Kienle, E ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Takeda Pharma GmbH   (Germany)

Author keywords

Endometriosis; GnRH analogues; Leuprorelinacetate

Indexed keywords

GONADORELIN; GONADORELIN AGONIST; LEUPRORELIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ENDOMETRIOSIS; ENDOMETRIUM TUMOR; FEMALE; HUMAN; LAPAROSCOPIC SURGERY; LAPAROSCOPY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PERITONEUM; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE CARE; PREGNANCY; PREGNANCY RATE;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; COMBINED MODALITY THERAPY; DELAYED-ACTION PREPARATIONS; ENDOMETRIOSIS; FEMALE; HUMANS; LAPAROSCOPY; LEUPROLIDE; PERITONEUM; PREGNANCY; PROSPECTIVE STUDIES; REOPERATION; TREATMENT OUTCOME;

EID: 0031956650     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Aleem FA, Predanic M: The hemodynamic effect of GnRH agonist therapy on uterine leiomyoma vascularity: a prospective study using transvaginal color Doppler sonography. Gynecol Endocrinol 9 (1995) 253-258
2. Bühler K: Therapieregime zur Behandlung der Endometriose: Einsatz in der täglichen gynäkologischen Praxis. Fertil 11 (1995) 1-4
3. Busacca M, Candiani M, Carlini L, Gonfiantini C, Vignali M: 3rd World Congress on Endometriosis. Brüssel/Belgien 1992, 31
4. Descamps P, Audebert A, Ory-Lavollée L, Bailleul F: Pre or post-operative medical treatment with nafarelin in stage III-IV endometriosis: A French multicenter study. In: Vth World Congress on Endometriosis. Abstract O-160, 21-24 October 1996, Pacifico Yokohama, Yokohama, Japan
5. Donnez J: Combination medical therapy with laparoscopy surgery. In: Vth World Congress on Endometriosis. Abstract O-52, 21-24 October 1996, Pacifico Yokohama, Yokohama, Japan
6. Evers JLH: The second-look laparoscopy for evalutions of the results of medical treatment of endometriosis should not be performed during ovarian suppression. Fertil Steril 47 (1987)
7. Garzetti GG, Ciavattini A, Provinciali M, Muzzioli M, Di Stefano Giuseppina, Fabris N: Natural cytotoxicity and GnRH agonist administration in advanced endometriosis: Positive modulation an natural killer activity. Obstet Gynecol 88 (1996) 234-230
8. Hefni MA: Comparison controlled study of GnRH analogue (goserelin) and laparoscopic diatheramy for the treatment of endometriosis. In: Vth World Congress on Endometriosis. Abstract P-156, 21-24 October 1996, Pacifico Yokohama, Yokohama, Japan
9. Hsu CC, Lin YS, Wang ST, Wu MS, Huang KE: Modulation of systemic immunologic with gonadotropin releasing hormone agonist in patients with advanced endometriosis. In: Vth World Congress on Endometriosis. Abstract O-95, 21-24 October 1996, Pacifico Yokohama, Yokohama, Japan
10. Jansen R, Russel P: Nonpigmented endometriosis. Clinical, laparoscopic and pathologic definition. Am J Obstet Gynecol 155 (1986) 1154-1159
11. Koninckx PR, Martin D: Treatment of deeply infiltrating endometriosis. Curr Opin Obstet Gynecol 6 (1994) 231-234
12. Koninckx PR, Meuleman C, Demeyere S, Lesaffre E, Cornillie FJ: Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain. Fertil Steril 55 (1991) 759-765
13. Martin DC: Surgical Treatment of Endometriosis. Clinical Consultations in Obstet Gynecol 7 (1995) 190-199
14. Mettler L, Semm K: Pelviscopy and its secrets: to detect and treat genital endometriosis Proceedings 4th World Congress of Endometriosis (1994) 327-333
15. Metzger DA, Szpak CA, Haney AF: Histologic features associated with hormonal responsiveness of ectopic endometrium. Fertil Steril 59 (1993) 83-88
16. 2-laser exciusion of endometriosis does not improve the decreased natural killer activity. Acta Obstet Gynecol Scand 73 (1994) 333-337
17. Redwine DB: Age-related evolution on color appearance of endometriosis. Fertil Steril 48 (1987) 1062-1063
18. Regidor PA, Schindler AE, Bühler K, Gerhard L, Kimmig R, Meinen K, Hoffmann G, Lübben G, Kienle E: Ergebnisse eines Langzeit Follow-up bei der Behandlung der Endometriose mit dem GnRH-Agonisten Leuprorelinacetat-Depot. Zentralbl Gynakol 118 (1996) 283-290
19. Rock JA, Truglia JA, Caplan RJ, The Zoladex Endometriosis Study Group: Zoladex (Goserelin Acetate Implant) in the Treatment of Endometriosis. A Randomized Comparison with Danazol. Obstet Gynecol 82 (1993) 198-205
20. Rock JA: Endometriosis and pelvic pain. Fertil Steril 60 (1993) 950-951
21. Schindler AE, Bühler K, Gerhard I, Wiedemann R, Kimmig R, Schüssler B, Kranzfelder D, Mall-Häfeli M, Meinen K, Mancarella D, Hoffmann G, Kienle E: Behandlung der Endometriose mit dem GnRH-Agonisten Leuprorelinacetat Depot (Enantone-Gyn® Monats-Depot): Eine multizentrische Studie. Zentralbl Gynakol 116 (1994) 679-686
22. Schweppe KW: GnRH-Agonisten in der Gynäkologie. Deutsches Ärzteblatt, Ausgabe A (1995) 36
23. Shaw RW: An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Fertil Steril 58 (1992) 265-272
24. Shaw RW: A risk benefit assessment of drugs used in the treatment of endometriosis. Drug Safety 11 (1994) 104-113
25. Spuijbroek MDEH, Dunselman GAJ, Menheere PPCA, Evers JLH: Early endometriosis invades the extracellular matrix. Fertil Steril 58 (1992) 929-933
26. Telimaa S, Puolakka J, Rönnberg L, Kauppila A: Placebo-controlled comparison of danazol and high-dose medroxy-progesterone acetate in the treatment of endometriosis. Gynecol Endocrinol 1 (1987) 13-23
27. Terakawa N: Effects of medical treatment on active lesions of peritoneal endometriosis. In: Vth World Congress on Endometriosis. Abstract O-47, 21-24 October 1996, Pacifico Yokohama, Yokohama, Japan
28. Thaele M, Thaele S, Bühler K, v. Seebarth HB: Differentialdiagnostik in der zytologischen Beurteilung der Endometriose. Frauenarzt 36 (1995) 340-343
29. Venturini PL, Semino A, de Cecco L: The biological basis of medical treatment of endometriosis. Gynecol Endocrinol 9 (1995) 259-266
30. Vernon MW, Beard JS, Graves K, Wilson EA: Classification of endometriosis implants by morphological appearance and capacity to synthesize prostaglandin F. Fertil Steril 46 (1986) 801-806
31. Waller KG, Shaw RW: Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up. Fertil Steril 59 (1993) 511-515
32. Winkel C, Bray M: Use of leuprolide acetate (LEUPRORELINACETAT) in combination with surgical treatment for women with endometriosis. In: Vth World Congress on Endometriosis. Abstract O-105, 21-24 October 1996, Pacifico Yokohama, Yokohama, Japan
33. Wright JA, Sharpe-Timms KL: Gonadotropin-releasing hormone agonist therapy reduces postoperative adhesion formation and reformation after adhesiolysis in rat models for adhesion formation and endometriosis. Fertil Steril 63 (1995) 1094-1100
34. Wu M-Y, Chao K-H, Chen S-U, Chen H-F, Yang Y, Huang S-C, Ho H-N: The suppression of peritoneal cellular immunity in women with endometriosis could be restored after gonadotropin releasing hormone agonist treatment. AJRI 35 (1996) 510-516